Bellevue Medtech & Services B Cap

Reference Data

ISIN LU0415391605
Valor Number 3882711
Bloomberg Global ID BBG000PM9WQ5
Fund Name Bellevue Medtech & Services B Cap
Fund Provider Bellevue Asset Management AG Zürich, Switzerland
Phone: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Fund Provider Bellevue Asset Management AG
Representative in Switzerland Waystone Fund Services (Switzerland) SA
Lausanne
Phone: 0041213111781
Distributor(s) Bank am Bellevue AG
Küsnacht
Phone: +41 44 267 67 67
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two-thirds of the net assets of the sub-fund in a portfolio of carefully chosen shares and other equity securities of companies in the medical technology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term “medtech and services”, companies in the medtech and services sector consist of companies primarily engaged in the production, development, funding, marketing and sale of medical devices and the provision of technical medical services, such as hospitals and laboratories, or the facilitation of processes relevant to these facilities; as well as entities primarily engaged in investing in or financing such companies.
Peculiarities

Fund Prices

Current Price * 447.08 CHF 30.10.2024
Previous Price * 447.85 CHF 29.10.2024
52 Week High * 462.63 CHF 27.03.2024
52 Week Low * 366.76 CHF 10.11.2023
NAV * 447.08 CHF 30.10.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 1,461,027,542
Unit/Share Assets ***
Trading Information SIX

Performance

YTD Performance +13.83% 29.12.2023
30.10.2024
1 month +0.78% 30.09.2024
30.10.2024
3 months +3.71% 30.07.2024
30.10.2024
6 months +1.46% 30.04.2024
30.10.2024
1 year +25.32% 30.10.2023
30.10.2024
2 years +3.29% 31.10.2022
30.10.2024
3 years -9.38% 02.11.2021
30.10.2024
5 years +20.74% 30.10.2019
30.10.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Boston Scientific Corp 9.83%
Intuitive Surgical Inc 9.79%
Abbott Laboratories 9.63%
Stryker Corp 8.91%
Medtronic PLC 4.88%
Becton Dickinson & Co 4.66%
Essilorluxottica 3.98%
Alcon Inc 3.88%
Edwards Lifesciences Corp 3.26%
GE HealthCare Technologies Inc Common Stock 2.53%
Last data update 31.08.2024

Cost / Risk

TER 2.23%
TER date 01.02.2021
Performance Fee ***
PTR
Max. Management Fee *** 1.60%
Ongoing Charges *** 2.16%
SRRI ***
SRRI date *** 30.09.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)